Contains full FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of color pill images, as well as dosages, clinical-trials, side effects, and safety.
This completely revised edition of the renowned guide presents everything readers need to know about prescription drugs based on the FDA-approved information published in the "Physicians Desk Reference." Original.
The new "2008 Red Book" not only presents the latest pricing and product information on more than 160,000 prescription and over-the-counter items, but also a complete list of newly FDA-approved brands, generics, and biologics.
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
PDR is the premier reference on prescription drugs and is found in nearly every physician’s office, clinic, hospital, pharmacy and library. Completely updated every year, PDR provides critical, current information on the most commonly prescribed drugs in the U.S. Every full, FDA-approved drug label in PDR includes: Dosages; Indications; Warnings and precautions; Side effects; Safety information such contraindications, pregnancy ratings; Interactions with other drugs, food, or alcohol; Clinical trials data. Comprehensive indexing by a drug’s brand and generic name, its manufacturer and therapeutic category gives users multiple, easy ways to access the information they seek. PDR also includes a product identification guide with hundreds of images of full-color images.
These texts were written in the vernacular for a readership of physicians and surgeons but also of midwives and lay women. So they present important evidence that, contrary to stereotypes, women were the recipients of medical texts written specifically for them. More generally, these texts demonstrate a strong interest in women's health, indicating that early modern physicians and surgeons had a new interest in the specificity of female anatomy and women's diseases. The texts selected and translated in this volume allow the reader to access an important group of primary sources on issues related to women's health, including childbirth and caesarean section, sterility, miscarriage, breastfeeding, etc. The selection of texts is well organized and coherent, the translation is accurate and fluent, and the texts are adequately annotated, so the book will be easily used by scholars and students, including undergraduates. It provides evidence of a new concern and attention for women's health needs, which, most interestingly, often went hand-in-hand with the rejection of misogynist stereotypes and the challenging of conventional views of female subordination and inferiority. --Gianna Pomata Professor of the History of Medicine, Johns Hopkins University